Position in JAZZ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$6,127,385
+$1,433,274 QoQ
Shares Held
25,428
+2.4% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#160
of 640 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Summit Trail Advisors, LLC holds $31,541,707 across 29 Biotechnology names. JAZZ ranks #1 (19.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
25,428 | $6,127,385 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,429 | $3,690,207 | |
| 3 | RPRX |
Royalty Pharma plc
|
39,362 | $2,207,027 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,083 | $1,922,373 | |
| 5 | MRNA |
Moderna, Inc.
|
24,030 | $1,682,820 | |
| 6 | TECH |
BIO-TECHNE Corp
|
22,807 | $1,611,314 | |
| 7 | INCY |
Incyte Corp
|
13,838 | $1,568,675 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
7,559 | $1,415,649 |
All Filings in JAZZ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,127,385 | 25,428 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $4,694,111 | 24,830 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,388,550 | 25,815 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,899,072 | 21,996 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,521,017 | 14,333 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $417,144 | 3,360 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $538,904 | 4,376 | Shares | Sole | 2025-01-29 | |
| No filing history on record for this holder in this stock. | ||||||